Jubilant Pharmova Limited (BOM:530019)

Jubilant Pharmova Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	10,883	9,564	10,139	9,838	5,020
Short-Term Investments	-	-	-	-	53.53	1,875
Cash & Short-Term Investments	10,888	10,883	9,564	10,139	9,892	6,894
Cash Growth	13.80%	13.79%	-5.67%	2.50%	43.48%	-51.39%
Accounts Receivable	-	10,043	10,134	10,508	9,914	8,693
Other Receivables	-	1,433	2,534	1,678	1,497	1,590
Receivables	-	11,487	12,676	12,197	11,426	10,294
Inventory	-	11,486	13,038	14,215	12,861	11,429
Prepaid Expenses	-	1,050	910	900	833.54	823.74
Other Current Assets	-	866	2,573	173	79.99	84.63
Total Current Assets	-	35,772	38,761	37,624	35,092	29,525
Property, Plant & Equipment	-	51,682	36,871	33,652	27,911	25,752
Long-Term Investments	-	435	422	2,564	2,386	2,541
Goodwill	-	25,410	24,639	24,286	22,428	21,300
Other Intangible Assets	-	10,967	10,433	9,510	9,263	8,006
Long-Term Deferred Tax Assets	-	2,574	2,327	2,275	1,613	1,547
Other Long-Term Assets	-	721	2,029	1,652	1,211	504.39
Total Assets	-	127,564	115,485	111,567	99,909	89,181
Accounts Payable	-	10,048	8,563	8,213	5,677	5,205
Accrued Expenses	-	3,947	3,293	2,786	3,091	2,846
Short-Term Debt	-	2,190	1,965	2,583	640	200.01
Current Portion of Long-Term Debt	-	676	505	414	3,994	-
Current Portion of Leases	-	556	521	534	521.93	501.34
Current Income Taxes Payable	-	184	370	624	345.06	468.11
Current Unearned Revenue	-	1,286	998	719	909.81	544.6
Other Current Liabilities	-	2,759	2,675	1,851	737.41	722.98
Total Current Liabilities	-	21,646	18,890	17,724	15,916	10,488
Long-Term Debt	-	21,503	31,671	31,104	24,642	25,640
Long-Term Leases	-	2,385	1,978	2,133	2,122	1,955
Long-Term Unearned Revenue	-	11,375	5,438	2,685	72.96	75.71
Long-Term Deferred Tax Liabilities	-	1,722	2,108	3,062	3,030	2,473
Other Long-Term Liabilities	-	5,832	647	459	445.45	602.28
Total Liabilities	-	65,178	61,274	57,649	46,745	41,766
Common Stock	-	158	158	159	159.28	159.28
Retained Earnings	-	53,018	45,397	45,368	46,860	43,187
Comprehensive Income & Other	-	9,373	8,784	8,466	6,166	4,069
Total Common Equity	62,549	62,549	54,339	53,993	53,186	47,415
Minority Interest	-	-163	-128	-75	-21.63	0.31
Shareholders' Equity	62,386	62,386	54,211	53,918	53,164	47,415
Total Liabilities & Equity	-	127,564	115,485	111,567	99,909	89,181
Total Debt	27,310	27,310	36,640	36,768	31,920	28,296
Net Cash (Debt)	-16,422	-16,427	-27,076	-26,629	-22,028	-21,401
Net Cash Per Share	-103.36	-103.40	-170.44	-167.32	-138.39	-134.37
Filing Date Shares Outstanding	158.55	158.4	158.35	159.07	159.17	159.17
Total Common Shares Outstanding	158.55	158.4	158.35	159.07	159.17	159.17
Working Capital	-	14,126	19,871	19,900	19,176	19,037
Book Value Per Share	395.41	394.89	343.16	339.43	334.14	297.88
Tangible Book Value	26,172	26,172	19,267	20,197	21,495	18,109
Tangible Book Value Per Share	165.45	165.23	121.67	126.97	135.04	113.77
Land	-	380	444	440	447.86	436.86
Buildings	-	7,459	8,622	8,498	7,957	7,744
Machinery	-	31,360	32,484	29,213	26,009	21,826
Construction In Progress	-	27,147	12,523	7,733	2,918	2,778

Source: S&P Global Market Intelligence. Standard template. Financial Sources.